tiprankstipranks
10x Genomics CFO says ‘pleased with how the quarter shaped up’
The Fly

10x Genomics CFO says ‘pleased with how the quarter shaped up’

Asked at the JPMorgan Healthcare Conference about whether the company has been seeing any meaningful impact in China over the last couple of months and how they see the China demand situation evolving in 2023, 10x Genomics CFO Justin McAnear replied: "Well, to start with your question on the macro environment, it has been a dynamic macro environment overall. As far as the quarter, I would say that overall, we’re pleased with how the quarter shaped up. We’re not doing a preannounce. Obviously, we’re not announcing the revenue, but we’re pleased with how the quarter shaped up. As far as China specifically, we called out some risks on our Q3 earnings call. Across the world, there was puts and takes that would impact Q4 and so I’m sure you all saw in the news, saw the level of disruption there. And so yes, there was a level of disruption there… So we’ll get to guidance on our February earnings call. But I think we have a good setup going into 2023. It’s the first full year of Xenium, Flex, CytAssist. But overall, the macro environment does remain dynamic and difficult to predict."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on TXG:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles